STOCK MARKET BSE NSE

Johnson & Johnson gets nod for Covid vaccine trials in India

The subject expert committee under the CDSCO on Covid-19 gave its approval on Monday after analysing the data from the pre-clinical trials or animal studies.

Published: 28th October 2020 06:35 PM  |   Last Updated: 28th October 2020 09:57 PM   |  A+A-

Coronavirus, Vaccine

Representational Image. (Photo | Shekhar Yadav, EPS)

Express News Service

NEW DELHI: The Central Drugs Standard Control Organisation (CDSCO) has approved human trials of a Covid-19 vaccine candidate by Hyderabad-based Biological E which has entered into an agreement with the USA’s drug maker Johnson & Johnson.

This is the fifth potential Covid-19 vaccine permitted for clinical trial in India. Earlier, Dr Reddy's Laboratories, Indian partner for the Russian Covid-19 vaccine Sputnik V, received a go-ahead to carry out phase 2 and 3 trials in the country.

The subject expert committee under the CDSCO on Covid-19 gave its approval on Monday after analysing the data from the pre-clinical trials or animal studies.
 
“After detailed deliberation, the committee recommended for grant of permission to conduct the Phase I/ II trial,” said the SEC. 

ALSO READ | Johnson & Johnson pauses COVID-19 vaccine trial as participant becomes ill

The vaccine maker will now soon start the phase 1 and 2 trial of the vaccine, developed with the SARS CoV 2 particles using adenovirus platform, in the country.

Biological E has got the technology transferred from J & J which has also given the company manufacturing rights of its SARS-Cov2 vaccine. 

The development comes as the US drugmaker announced at the World Health Summit that the initial batches of its Covid-19 vaccine could be available for emergency use as early as January. 

The company is looking to restart a large late-stage trial of the vaccine that had been halted due to safety concerns. The study involving 60,000 individuals is expected to have initial results by the end of the year.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

IPL_2020
flipboard facebook twitter whatsapp